Suspected adverse reactions to oral administration of a praziquantel-pyrantel combination in captive cheetahs (Acinonyx jubatus)

Tools

Whitehouse-Tedd, KM ORCID: https://orcid.org/0000-0003-0061-489X, Smith, L, Budd, JA and Lloyd, CG, 2017. Suspected adverse reactions to oral administration of a praziquantel-pyrantel combination in captive cheetahs (Acinonyx jubatus). Journal of the American Veterinary Medical Association, 251 (10), pp. 1188-1195. ISSN 0003-1488

Preview

Text
9507_Whitehouse-Tedd.pdf - Published version
Download (8MB) | Preview

Official URL: http://doi.org/10.2460/javma.251.10.1188

Abstract

Objective: To characterize adverse reactions to oral administration of a combination of praziquantel and pyrantel embonate or pyrantel pamoate, with or without oxantel embonate, in captive cheetahs (Acinonyx jubatus).
Design: Retrospective case series and case-control study.
Animals: 16 captive cheetahs with signs of adverse reaction to oral administration of praziquantel and pyrantel, with or without oxantel embonate (affected group), and 27 cheetahs without such reactions (unaffected group), all from 3 independent facilities.
Procedures: Medical records and postmortem findings for affected cheetahs were reviewed and compared with those of unaffected animals. Anthelmintic doses administered, age, and sex of cheetahs were compared between groups.
Results: 3 reactions in affected cheetahs were fatal, whereas the remainder ranged from mild to severe. Postmortem examination failed to reveal any disease processes or conditions to explain the deaths. No differences in anthelmintic dose were identified between affected and unaffected cheetahs for all facilities combined, and no correlation existed between dose and reaction severity. No association with sex was detected, but affected cheetahs were significantly younger than unaffected cheetahs. This difference was not significant after controlling for facility.
Conclusions and clinical relevance: Cheetahs were concluded to have had an adverse reaction to the praziquantel-pyrantel combination because of temporal proximity of onset of clinical signs to dose administration, similarity of signs to those reported for toxicosis in other species for these drugs, and a lack of other disease process or environmental explanatory factors. A highly cautious approach to the use of this drug combination is recommended for cheetahs.

Item Type:	Journal article
Publication Title:	Journal of the American Veterinary Medical Association
Creators:	Whitehouse-Tedd, K.M., Smith, L., Budd, J.A. and Lloyd, C.G.
Publisher:	American Veterinary Medical Association
Date:	15 November 2017
Volume:	251
Number:	10
ISSN:	0003-1488
Identifiers:	Number Type 10.2460/javma.251.10.1188 DOI
Divisions:	Schools > School of Animal, Rural and Environmental Sciences
Record created by:	Jonathan Gallacher
Date Added:	16 Nov 2017 09:58
Last Modified:	09 Nov 2018 03:00
URI:	https://irep.ntu.ac.uk/id/eprint/32036